Latest traumatic brain injury Stories

University of Washington Costly intracranial pressure monitoring re-examined by researchers in US and Latin America For patients with a traumatic brain injury, the default standard of care has just been turned on its head by a group of researchers at the University of Washington working with colleagues at six hospitals in Bolivia and Ecuador. In a study published in the New England Journal of Medicine Dec. 12, the researchers found that intracranial pressure monitoring – the...

Clinical study suggests potential benefit of using advanced imaging techniques to monitor recovery Brain changes in children who have sustained a mild traumatic brain injury, or concussion, persist for months following injury — even after the symptoms of the injury are gone, according to a study published in the December 12 issue of The Journal of Neuroscience. The findings highlight the potential benefit of using advanced imaging techniques to monitor recovery in children following...

SUNNYVALE, Calif., Dec. 11, 2012 /PRNewswire/ -- Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced the launch of a suite of online digital corporate communication channels to maintain on-going direct communication with shareholders. The Company has launched official portals on various social...

A Virginia woman received $1.9 million compensation for medical expenses, lost wages and special needs related to a car accident that caused severe injuries and permanent disability. Washington, D.C. (PRWEB) December 04, 2012 The Mike Slocumb Law Firm today announced that auto accident lawyers in Washington, D.C., obtained a $1.9 million settlement on behalf of a woman who was seriously injured last year, after the driver of a commercial vehicle ran a red light and slammed into her car,...

SUNNYVALE, Calif., Dec. 4, 2012 /PRNewswire/ -- Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that it has appointed former Super Bowl Champion Toi Cook to its Board of Advisors. Mr. Cook will work with Company management to engage the National Football League (NFL), NFL Players Association...

Lee Rannals for redOrbit.com – Your Universe Online Findings reported in the journal Brain help to extend the knowledge of the clinical and pathological abnormalities associated with chronic traumatic encephalopathy. A new study examined the brains of 68 new cases of four progressive stages of chronic traumatic encephalopathy (CTE). CTE is associated with repeated brain trauma and has been found in professional athletes, military veterans, and some people who injure themselves with...

LUND, Sweden, December 3, 2012 /PRNewswire/ -- NeuroVive announces publication of the results of a Phase I clinical trial of lead product CicloMulsion(R) in the scientific journal Clinical Drug Investigation. The paper highlights that the intravenous cyclosporine formulation CicloMulsion(R) demonstrates bioequivalence and improved tolerability when compared with Sandimmune(R) Injection. The mitochondrial medicine company NeuroVive Pharmaceutical today announces...

Using a special magnetic resonance imaging (MRI) technique to image patients with mild traumatic brain injury (MTBI), researchers have identified a biomarker that may predict which patients will do well over the long term, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). The results of the study showed that in some patients the brain may have changed to compensate for the damage caused by the injury. "This finding has huge...

CHICAGO, Nov. 26, 2012 /PRNewswire-USNewswire/ -- Using a special magnetic resonance imaging (MRI) technique to image patients with mild traumatic brain injury (MTBI), researchers have identified a biomarker that may predict which patients will do well over the long term, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). The results of the study showed that in some patients the brain may have changed to compensate for the...

MRI shows changes in the brains of people with post-concussion syndrome (PCS), according to a new study published online in the journal Radiology. Researchers hope the results point the way to improved detection and treatment for the disorder. PCS affects approximately 20 percent to 30 percent of people who suffer mild traumatic brain injury (MTBI)—defined by the World Health Organization as a traumatic event causing brief loss of consciousness and/or transient memory dysfunction or...